NAVIDEA BIOPHARMACEUTICALS, INC.·4

Feb 20, 4:39 PM ET

Latkin Jed 4

4 · NAVIDEA BIOPHARMACEUTICALS, INC. · Filed Feb 20, 2020

Insider Transaction Report

Form 4
Period: 2020-02-20
Latkin Jed
Interim COO
Transactions
  • Purchase

    Common Stock

    2020-02-20$1.08/sh+5,000$5,40017,950 total

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4